ABOS (Acumen Pharmaceuticals) Cash per Share: $1.78 (As of Mar. 2026)

What is Acumen Pharmaceuticals Cash per Share?

Acumen Pharmaceuticals ABOS -2.59% 34 Cash per Share is $1.78 as of Mar. 2026. GuruFocus rates ABOS with a GF Score™ of 34/100. The stock has 3 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Acumen Pharmaceuticals's Cash per Share for the quarter that ended in Mar. 2026 was $1.78.

Acumen Pharmaceuticals (NAS:ABOS) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Acumen Pharmaceuticals Cash per Share Related Terms

Acumen Pharmaceuticals Cash per Share Historical Data

* Premium members only.

The historical data trend for Acumen Pharmaceuticals's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acumen Pharmaceuticals Cash per Share Chart

Acumen Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Cash per Share

Get a 7-Day Free Trial

4.80

4.33

4.21

2.86

1.93

Acumen Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Cash per Share	Get a 7-Day Free Trial															2.46	2.37	2.09	1.93	1.78

34GF Score

Acumen Pharmaceuticals Inc ABOS

Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Acumen Pharmaceuticals Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Acumen Pharmaceuticals's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	116.865	/	60.58
	=	1.93

Acumen Pharmaceuticals's Cash per Share for the quarter that ended in Mar. 2026 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	128.398	/	72.23
	=	1.78

Frequently Asked Questions Learn more about Cash per Share →

What does a Cash per Share of $1.78 mean?

Acumen Pharmaceuticals (ABOS) has a Cash per Share of $1.78 as of Mar. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Acumen Pharmaceuticals and its competitors.

Is Acumen Pharmaceuticals' Cash per Share too high?

Acumen Pharmaceuticals' current Cash per Share is $1.78. Overall, Acumen Pharmaceuticals has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.

How does Acumen Pharmaceuticals' Cash per Share compare to YDES and PYXS?

Acumen Pharmaceuticals' Cash per Share of $1.78 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Cash per Share for a Biotechnology company?

A good Cash per Share depends on the Biotechnology industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Cash per Share mean?

A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Acumen Pharmaceuticals and its competitors. Acumen Pharmaceuticals's current Cash per Share is $1.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Acumen Pharmaceuticals stock overvalued right now?

Acumen Pharmaceuticals (ABOS) has a current Cash per Share of $1.78. The current Cash per Share is $1.78. Acumen Pharmaceuticals' overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Cash per Share calculated?

Cash per Share is calculated from a company's financial statements. For Acumen Pharmaceuticals (ABOS), the current Cash per Share is $1.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acumen Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies YDES PYXS CRBU PRQR CRBP NRXP LENZ KRRO ANTX OKUR VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 1210-1220 Washington Street, Suite 210, Newton, MA, USA, 02465

Website https://www.acumenpharm.com

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

34GF Score

Get the complete analysis for ABOS

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.63

Price

View ABOS Analysis

See Cash per Share data for all stocks →